Logo image of ABCM

ABCAM PLC-SPON ADR (ABCM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ABCM - US0003802040 - ADR

23.99 USD
+0.01 (+0.04%)
Last: 12/5/2023, 8:00:00 PM
23.99 USD
0 (0%)
After Hours: 12/5/2023, 8:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ABCM. ABCM was compared to 528 industry peers in the Biotechnology industry. ABCM has an average financial health and profitability rating. ABCM is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ABCM was profitable.
ABCM had a positive operating cash flow in the past year.
ABCM Yearly Net Income VS EBIT VS OCF VS FCFABCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

1.2 Ratios

ABCM has a better Return On Assets (0.64%) than 93.86% of its industry peers.
ABCM has a better Return On Equity (0.93%) than 93.86% of its industry peers.
The Return On Invested Capital of ABCM (1.98%) is better than 94.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ABCM is significantly below the industry average of 18.28%.
The 3 year average ROIC (6.00%) for ABCM is well above the current ROIC(1.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROIC 1.98%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ABCM Yearly ROA, ROE, ROICABCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

ABCM's Profit Margin of 1.94% is amongst the best of the industry. ABCM outperforms 94.86% of its industry peers.
ABCM's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 8.70%, ABCM belongs to the best of the industry, outperforming 95.36% of the companies in the same industry.
In the last couple of years the Operating Margin of ABCM has declined.
The Gross Margin of ABCM (72.69%) is better than 83.58% of its industry peers.
ABCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
ABCM Yearly Profit, Operating, Gross MarginsABCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 20 40 60

4

2. Health

2.1 Basic Checks

ABCM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ABCM has more shares outstanding
The debt/assets ratio for ABCM has been reduced compared to a year ago.
ABCM Yearly Shares OutstandingABCM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
ABCM Yearly Total Debt VS Total AssetsABCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.64 indicates that ABCM is not in any danger for bankruptcy at the moment.
The Altman-Z score of ABCM (8.64) is better than 85.41% of its industry peers.
The Debt to FCF ratio of ABCM is 19.99, which is on the high side as it means it would take ABCM, 19.99 years of fcf income to pay off all of its debts.
ABCM has a better Debt to FCF ratio (19.99) than 94.03% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that ABCM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.30, ABCM is doing worse than 71.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Altman-Z 8.64
ROIC/WACC0.22
WACC8.89%
ABCM Yearly LT Debt VS Equity VS FCFABCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.26 indicates that ABCM should not have too much problems paying its short term obligations.
ABCM's Current ratio of 1.26 is on the low side compared to the rest of the industry. ABCM is outperformed by 86.73% of its industry peers.
A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
ABCM has a Quick ratio of 0.98. This is amonst the worse of the industry: ABCM underperforms 88.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.98
ABCM Yearly Current Assets VS Current LiabilitesABCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 402.64% over the past year.
ABCM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.30% yearly.
The Revenue has grown by 17.70% in the past year. This is quite good.
Measured over the past years, ABCM shows a quite strong growth in Revenue. The Revenue has been growing by 11.64% on average per year.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%

3.2 Future

ABCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.12% yearly.
ABCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.28% yearly.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABCM Yearly Revenue VS EstimatesABCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
ABCM Yearly EPS VS EstimatesABCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 44.43, which means the current valuation is very expensive for ABCM.
Based on the Price/Earnings ratio, ABCM is valued cheaper than 94.69% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.19. ABCM is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 49.32 indicates a quite expensive valuation of ABCM.
94.53% of the companies in the same industry are more expensive than ABCM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.92, ABCM is valued quite expensively.
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
ABCM Price Earnings VS Forward Price EarningsABCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABCM is valued cheaply inside the industry as 94.20% of the companies are valued more expensively.
93.86% of the companies in the same industry are more expensive than ABCM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 374.67
EV/EBITDA 55.61
ABCM Per share dataABCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABCM has a very decent profitability rating, which may justify a higher PE ratio.
ABCM's earnings are expected to grow with 52.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%

0

5. Dividend

5.1 Amount

ABCM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ABCAM PLC-SPON ADR

NASDAQ:ABCM (12/5/2023, 8:00:00 PM)

After market: 23.99 0 (0%)

23.99

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-12 2022-09-12/dmh
Earnings (Next)N/A N/A
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Revenue(TTM)350.40M
Net Income(TTM)6.80M
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
P/S 12.3
P/FCF 374.67
P/OCF 79.64
P/B 5.92
P/tB 42.37
EV/EBITDA 55.61
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROCE 3.54%
ROIC 1.98%
ROICexc 2.23%
ROICexgc 7.95%
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
FCFM 3.28%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexgc growth 3Y-57.08%
ROICexgc growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Debt/EBITDA 2.79
Cap/Depr 90.64%
Cap/Sales 12.16%
Interest Coverage 9.53
Cash Conversion 69.81%
Profit Quality 169.12%
Current Ratio 1.26
Quick Ratio 0.98
Altman-Z 8.64
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%

ABCAM PLC-SPON ADR / ABCM FAQ

Can you provide the ChartMill fundamental rating for ABCAM PLC-SPON ADR?

ChartMill assigns a fundamental rating of 6 / 10 to ABCM.


Can you provide the valuation status for ABCAM PLC-SPON ADR?

ChartMill assigns a valuation rating of 7 / 10 to ABCAM PLC-SPON ADR (ABCM). This can be considered as Undervalued.


What is the profitability of ABCM stock?

ABCAM PLC-SPON ADR (ABCM) has a profitability rating of 8 / 10.


What is the valuation of ABCAM PLC-SPON ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ABCAM PLC-SPON ADR (ABCM) is 44.43 and the Price/Book (PB) ratio is 5.92.


What is the earnings growth outlook for ABCAM PLC-SPON ADR?

The Earnings per Share (EPS) of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 125.95% in the next year.